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The Journal of Immunology
Adaptive from Innate: Human IFN-g+CD4+ T Cells Can
Arise Directly from CXCL8-Producing Recent Thymic
Emigrants in Babies and Adults
Abhishek Das,* Kevin Rouault-Pierre,† Shraddha Kamdar,* Iria Gomez-Tourino,*
Kristie Wood,‡ Ian Donaldson,x Charles A. Mein,x Dominique Bonnet,† Adrian C. Hayday,*,†
and Deena L. Gibbons*
We recently demonstrated that the major effector function of neonatal CD4+ T cells is to produce CXCL8, a prototypic cytokine of
innate immune cells. In this article, we show that CXCL8 expression, prior to proliferation, is common in newly arising T cells (so-
called “recent thymic emigrants”) in adults, as well as in babies. This effector potential is acquired in the human thymus, prior to
TCR signaling, but rather than describing end-stage differentiation, such cells, whether isolated from neonates or adults, can
further differentiate into IFN-g–producing CD4+ T cells. Thus, the temporal transition of host defense from innate to adaptive
immunity is unexpectedly mirrored at the cellular level by the capacity of human innate-like CXCL8-producing CD4+ T cells to
transition directly into Th1 cells. The Journal of Immunology, 2017, 199: 1696–1705.
T
he discovery that neonatal T cells are extremely poor pro-
ducers of IFN-g has fueled the hypothesis that the neonatal
immune system is intrinsically anti-inflammatory, perhaps to
perturb overexuberant responses to self-antigens and nonpathogenic
commensals. However, this presumably must accommodate mecha-
nisms to protect against foreign pathogens (1). In this regard, we
found, surprisingly, that human CD4+ T cells from preterm and
term neonates harbor proinflammatory capacity in the form of CXCL8
production, an antimicrobial chemokine with a potent capacity to
recruit neutrophils (2–4).
A key question raised by this finding was whether CXCL8-
producing CD4+ T cells are inherently different from adult effec-
tor T cells, consistent with the reported discontiguity of fetal and
adult hematopoiesis (5), or whether newly arising CD4+ T cells in
adult humans can likewise produce CXCL8. Were this to be the
case, do such cells comprise a hitherto overlooked “Th8” subset,
or are they developmental intermediates in the differentiation of
other human T cell lineages? For example, IFN-g/IL-13–producing
murine dendritic epidermal gd T cells arise from progenitors with
the potential to produce IL-17 (6). Moreover, it was reported that
IL-17–producing ab T cells are not necessarily a differentiation
end point but may convert to IFN-g production (7). These ob-
servations are particularly germane, given that mice lack CXCL8,
with some of its functions including neutrophil recruitment at-
tributed to IL-17 (8, 9).
To address these key questions, we have tracked the development
of human CD4+ effector function from the thymus to the periphery.
We show that CXCL8 expression is imprinted early during thymic
development, prior to TCR signaling, that it is retained in T line-
age–committed cells, and that it is subsequently enriched in recent
thymic emigrants (RTEs) in adults, as well as in children. Fur-
thermore, we show that CXCL8+ CD4+ T cells from neonates or
adults can serve as direct precursors of human IFN-g–producing
CD4+ Th1 cells. Thus, the most naive peripheral T cells in adults,
as well as in neonates, have the potential for CXCL8 production, a
fact that may have been overlooked because of reduced thymic
output in adults and the cells’ rapid conversion to Th1 cells. These
data provide novel insights into human T cell ontogeny, illustrating
how conventional adaptive lymphocyte immunity can arise from
innate-like cells, rather than from functionless T cell progenitors
(Th0 cells), as has been considered the norm.
Materials and Methods
Human samples
Normal human umbilical cord blood (CB) samples were obtained from the
Royal London Hospital under ethical approval (HRECO6/Q0604/110) and
from the Anthony Nolan Research Biobank (15/EM/0045). Thymus tissue
was obtained from the Evelina Children’s Hospital (09/H0504/39). Blood
from children was obtained in collaboration with Dr. C. Furness and Prof.
M. Greaves at the Institute for Cancer Research using United Kingdom
Childhood Cancer Study stored samples from patients with nephro-
blastoma or neuroblastoma (CCR2285); adult blood was obtained from
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healthy volunteers (07/H0803/237). T cell acute lymphocytic leukemia
(T-ALL) samples were obtained from the Bloodwise Childhood Leu-
kaemia Cell Bank (16/SW/0219). Mononuclear cells were isolated from
blood by centrifugation using Ficoll-Paque PLUS (GE Healthcare Life
Sciences). For CB, mononuclear cells were enriched in CD34+ cells
(STEMCELL Technologies), and the CD342 fraction (on occasion from
pooled donors) was used for experiments.
Immunodeficient mice
NOD-SCID IL-2Rgnull (NSG) mice were a kind gift from Dr. Leonard
Shultz (The Jackson Laboratory, Bar Harbor, ME). Twenty-four hours
before transplantation, mice were sublethally irradiated (375 cGy). CD34+
cells were transplanted into 8–12-wk-old NSG mice using intrabone
marrow injection, and blood samples were collected from the tail at dif-
ferent time points. All animal work was undertaken in accordance with UK
Home Office guidelines.
Flow cytometry and cell sorting
Individual cell subsets were sorted (FACSAria II; Becton Dickinson) from
thymocytes, CB, or PBMCs using BioLegend Abs: anti-CD4 Pacific Blue
(OKT4), anti-CD8a allophycocyanin Cy7 (HIT8A), anti-CD34 Alexa
Fluor 647 (581), anti-CD7 PE Cy7 (CD7-6B7), anti-CD3 allophyco-
cyanin Cy7 (HIT3a), anti-CD31 Alexa Fluor 647 (WM59), and anti-CD45RA
PECy7 (HI100; BD Pharmingen).
Flow cytometry analysis was performed using a BD FACSCanto II. Cells
were stained with LIVE/DEAD fixable aqua stain (Thermo Fisher) prior
to staining with the Abs above and anti-TCR gd PE Cy7 (B1), anti-CD5
PerCP Cy5.5 (L17F12), or anti-CD1a PE (HI149; all from BioLegend).
For intracellular staining, cells were fixed (CellFIX; BD), permeabilized
(Perm/Wash Buffer; BioLegend), and stained with anti-CXCL8 FITC
(E8N1), anti–IFN-g PerCP Cy5.5 (4S.B3), anti–IL-2 PerCP Cy5.5 (MQ1-
17H12), or anti–IFN-g PE (B27).
For TCR excision circle (TREC) PCR, a modified intracellular cy-
tokine staining protocol was used to maximize DNA quality postex-
posure to fixative. Cells were sorted after surface staining in PBS with
anti-CD4 Pacific Blue, anti-CD3 allophycocyanin Cy7, anti-CD45RA
PE/Cy7, and anti-CD31 Alexa Fluor 647 (BioLegend), followed by
fixation in 1% paraformaldehyde (20 min) and intracellular staining for
anti-CXCL8 FITC and anti–IL-2 PerCP Cy5.5 (BioLegend) in 0.1% saponin
(25 min). Two additional washes in cold PBS were performed prior to
acquisition.
Cell stimulation
Total or individually sorted cells were stimulated with PMA (10 ng/ml) and
ionomycin (1 mg/ml; both from Sigma) or anti-CD3+CD28 Dynabeads
(1:1 ratio with cells; Thermo Fisher) in complete medium (RPMI 1640
medium containing 100 U penicillin and 100 mg/ml streptomycin [Invi-
trogen] and 10% FCS [STEMCELL Technologies]). For intracellular
FACS, Brefeldin A (BFA; 20 mg/ml; Sigma) was added. In assays in which
prolonged stimulation was required, IL-7 (10 ng/ml; PeproTech) was added.
For cell tracer experiments, CD4+ T cells were stained with a CellTrace
Violet Cell Proliferation Kit (Thermo Fisher). A total of 0.23 106 cells were
then resuspended in CM containing IL-7 (10 ng/ml), with or without anti-
CD3+CD28 beads. After 5 d, cells were restimulated with PMA plus
ionomycin (PI) prior to cytokine analysis.
Real-time PCR for TRECs
To preserve DNA quality within fixed cells, intracellular cytokine staining was
modified as described above. DNA was extracted from individual sorted cell
subsets using the DNeasy Blood and Tissue Kit (QIAGEN), using a modified
protocol. In brief, 10 ml of proteinase K was added to cells suspended in
200 ml of PBS, followed by Buffer AL. Cells were incubated at 56˚C for
12 min and then for 1 h at 80˚C, with agitation prior to the addition of
ethanol. The remaining steps were carried out as per the kit manufacturer’s
protocol. Signal joint TREC numbers were quantified with a real-time
PCR-based assay, as described previously (10). DNA concentration was
assessed using a NanoDrop Spectrophotometer, and the ratio of absorbance
at 260 and 280 nm was used to assess purity. An absorbance ratio . 1.8
was achieved in the majority of cases; however, in all cases, quality was
sufficient for quantitative PCR (qPCR).
FluoroSpot
IFN-g/CXCL8 production was assessed in sorted CD4+ T cells using the
IFN-g/CXCL8 FluoroSpot Kit (Mabtech). Stimulation conditions were
overnight (20 h): PI or anti-CD3+CD28 beads (1:1 ratio with cells) and
72 h: anti-CD3+CD28 beads, followed by PI for the last 20 h of stim-
ulation. Duplicate wells were set up for each stimulation condition. IL-7
(10 ng/ml) was added to all wells. Enumeration of fluorescent spots was
automated using a Fluorospot plate reader (BIOREADER 6000-F beta;
Bio-Sys).
T cell cloning from FluoroSpot plates
Negatively selected CD4+ T cells from CB (CD4+ T Cell Isolation Kit,
human; Miltenyi Biotec) were incubated for 2 h with PI. They were then
stained and single cell sorted (gated on 7-aminoactinomycin D negative,
CD3+CD4+CD31+CD45RA+ T cells) directly into a 96-well CXCL8/IFN-g
FluoroSpot plate containing 100 ml per well of X-VIVO 15 medium
(Lonza) and 10% human AB serum. Following a 20-h incubation to allow
cytokine capture on the membrane, individual cells were removed with a
pipette from the FluoroSpot plate and transferred directly into the corre-
sponding well of a 96-well round-bottom plate for cloning. An additional
50 ml of X-VIVO medium containing 10% human AB serum was used to
wash each FluoroSpot well to increase the probability of cell recovery and
transferred into the 96-well round-bottom plate. The FluoroSpot plate, now
with all cells removed, was washed, and the assay was conducted according
to the manufacturer’s instructions.
To clone transferred single cells, irradiated APCs (1:100,000) and PHA
(4 mg/ml; Thermo Fisher) were added to make the final volume in the well
200 ml. Additional irradiated APCs were added at days 10, 25, and 38.
T cell growth factor (5%; Helvetica Health Care) was added to wells
after day 3. At days 35 and 53, clones were isolated, surface stained, and
intracellularly stained for anti–IL-17A allophycocyanin (BL168), anti–
IL-4 PE (MP4-25D2), anti–IL-2 PE Cy7 (MQ1-17H12), anti–IFN-g
PerCP Cy5.5 (4S.B3), and anti-CXCL8 FITC (BioLegend). At the same
time points, cells were sorted for TCR sequencing to validate clonality
(see below).
Validation of single-cell FluoroSpot assay
Because this was the first description, to our knowledge, of single-cell
sorting onto a FluoroSpot plate and acquisition thereafter, the following
validation steps were implemented. First, cell counting was automated by
the Bio-Sys BIOREADER and quantitated as 0, 1, or .1 spots. A total of
544 wells were analyzed. Any well with 0 or .1 spot was discarded; only
wells counted as “1” were analyzed further. Second, to identify a single
CXCL8-producing cell, all wells with a single red spot (CXCL8 Cy3+; red)
were included. Any well with a green spot (IFN-g FITC+; green) or a yellow
spot (CXCL8 Cy3+ + IFN-g FITC+) was discarded. Third, all wells with a
single red spot were scrutinized for atypical morphology (most likely
representing debris) and, if present, were discarded. Finally, all wells with
a single red spot (CXCL8 Cy3+) meeting the above criteria were reimaged
on the AID Bioreader as further validation. Thus, 29 of 544 wells (5.3%)
were deemed to have a single Cy3+ signal.
Single-cell RNA sequencing
CD4+ T cells from CB samples (n = 2) were isolated (negative selection)
by cell sorting and activated for 2.5 h with PI. Single cells were captured
using the C1 Single-Cell Auto Prep System (Fluidigm, San Francisco, CA)
along with the SMARTer kit for cDNA generation (Clontech, Mountain
View, CA). One microliter of ERCC spike-in mix (Life Technologies,
Carlsbad, CA) was included (1:1000). Briefly, 1000 cells were loaded onto
each array (C-Chip; INCYTO, Cheonan-si Chungnam-do, Korea). The first
array yielded 43 single cells, and the second yielded 61. cDNA quantity
and quality were measured using a Qubit 2.0 Fluorometer (Life Technol-
ogies) and an Agilent 2200 TapeStation (Agilent Technologies, Wald-
bronn, Germany). A total of 96 single cells (55 from one cord and 41 from
another) were chosen for RNA sequencing, selecting cells with a range of
CXCL8 expression (as determined by real-time PCR). Libraries were
prepared using the Illumina Nextera XT Sample Preparation Kit (Illumina,
Cambridge, U.K.). Seventy-five–base pair paired-end reads were generated
using the Illumina NextSeq 500 System. Paired-end RNA sequencing
reads from these samples were simultaneously aligned to the human
genome (GRCh37/hg19) and ERCC92 spike-in control sequence using
TopHat v2.0.4 (11) and Bowtie2 v2.0.0.beta6 (12). Raw sequence counts
mapped to genes or ERCC spike-in controls were obtained using htseq-
count (13). Total gene counts were normalized to ERCC spike-in control
read counts using DESEquation (14). Differentially expressed genes
were those that showed statistically significant evidence [after multiple
hypothesis correction using a false discovery rate of 0.1 (15)] against
the null hypothesis that their biological coefficient of variation
was ,50% (i.e., CV2 , 0.25) (16). Data have been submitted to the
Gene Expression Omnibus under accession number GSE84686 (https://
www.ncbi.nlm.nih.gov/geo/).
The Journal of Immunology 1697
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Single-cell TCR sequencing
Sorted single live CD4+ T cells were collected, and single-cell nested
PCR for TCRA was performed as described previously (17). PCR
products were Sanger sequenced using the HTSP-tag primer, results were
referenced to the IMGT database (18), and the CDR3A sequences were
compared across individual cells using KNIME 2.11.2 (19).
TCR sequencing from whole-cell pellets
Sorted live CD4+ T cells were collected, snap-frozen, and stored at
280˚C. Whole-cell pellets were sent to Adaptive Biotechnologies
(Seattle, WA) for DNA extraction and TCR sequencing. Cells were
identified as clonal based on confidence levels established by Adaptive
Biotechnologies.
FIGURE 1. CXCL8-producing T cells decline with age in humans and in vivo in humanized mice and are enriched in RTEs. (A) CXCL8 production was
determined in naive CD4+ T cells (4 h PI + BFA) obtained from 45 individuals (aged between 3 mo and 57 y). (B) Irradiated NSG mice were reconstituted
with human CD34+ cells (CB derived). The graph shows reconstitution of T cells over time in individual mice (gray lines), with a reciprocal decline in T
cell production of CXCL8 (black lines). (C) FACS plots show an example of this reciprocal change in one reconstituted NSG mouse; percentage of cells
expressing CD3 within human CD45+ cells (upper panels) and percentage of cells expressing CXCL8 among CD3 T cells (lower panels; PI + BFA or BFA
alone for 4 h). CD4+ T cells from adults (D and F) or children aged 1–12 y (E) were activated with PI (4 h), and cytokine production was determined by
intracellular staining. Individual (cytokine+) subsets were then sorted, and TREC content was determined by qPCR. Results are shown as TREC levels per
million naive CD4+ cells or TREC levels per million total CD4+ cells in (F), because very few naive CD4+ cells express IFN-g. Trend lines depict the
differences in TREC levels among the four sorted populations in three patients. (G) CXCL8 production was determined following activation in vitro with PI
(4 h, in the presence of BFA) in primary T-ALL samples (n = 12); later stages (T-III/T-IV) are represented by gray diamonds.
1698 Th1 CELLS CAN DERIVE FROM CXCL8-PRODUCING RTEs
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Statistical analysis
A nonparametric paired Wilcoxon test was used for all paired data. Error
bars on graphs represent SD around the mean.
Results
CD4+ RTEs in adults express CXCL8
CXCL8 production is the most highly represented functional po-
tential among naive CD4+ T cells from neonates (2). Thus, when
naive CD4+ T cells (as determined by CD45RA and CD31 expres-
sion) from 45 donors of different ages were examined following
polyclonal activation, CXCL8 production was highest in babies and
was strongly and negatively correlated with age (R2 = +0.57, p , 1.7
3 1029). Nevertheless, CXCL8-producing T cells accounted for
∼10% of naive CD4+ T cells of several donors aged between 20 and
45 y (Fig. 1A).
A similar observation was made in NSG mice humanized by in-
oculation with CD34+ hematopoietic stem progenitor cells following
FIGURE 2. CXCL8 production is imprinted in the thymus. CXCL8 production was determined following activation in vitro with PI (4 h, in the presence of BFA) in
whole thymocytes versus peripheral blood from humanized mice (37 wk post–hematopoietic stem cell inoculation, n = 7) (A), sorted human thymocyte subsets (n = 15,
CD42CD82DN, CD4+CD8+ double positive, CD42CD8+ SP CD8, CD4+CD82 SP CD4+) (B), and enriched T-lineage–committed DN thymocytes (defined as CD42
CD82CD34+CD7+CD5+CD1a+, n = 6) (C). Example and cumulative data are shown. Stimulation: BFA only in dark gray and PI+BFA in light gray. (D) Comparison of
CXCL8 production between paired human SP CD4+ thymocytes and naive (CD31+CD45RA+) peripheral CD4+ T cells (n = 10). *p , 0.05, **p , 0.001.
FIGURE 3. Results of single-cell RNA sequencing. (A) PC analysis of expression data. Each point represents a sample whose expression data has been
projected onto the first two PCs for the expression data subset that includes all genes with statistically significant differential expression. (B) Genes
providing the largest contribution to weightings for PC1.
The Journal of Immunology 1699
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irradiation. PI induced CXCL8 production, by up to .30% of the
first-arising human T cells at ∼13–15 wk postinoculation; thereafter,
CXCL8 production declined dramatically as the representation of
human CD3+ T cells increased (Fig. 1B, 1C).
The age-related decline in the capacity of naive human T cells to
produce CXCL8mirrored the documented decline in thymic output
(20). Therefore, to determine whether CXCL8 production was a
feature unique to RTEs, it was measured in relation to TRECs,
which are the most reliable (and clinically applied) marker of
RTEs (10, 21). CD4+ T cells from adults aged 21–57 y were
stimulated with PI for 4 h and stained for intracellular cytokine
production using a protocol that preserves DNA quality. Subsets
of naive CD31+CD45RA+ cells that expressed CXCL8, CXCL8
plus IL-2, IL-2 alone, or neither CXCL8 nor IL-2 were isolated
by flow cytometry, and TREC levels were assessed by qPCR.
CXCL8+ cells were highly enriched in TRECs relative to cells
producing IL-2 alone (p = 0.002) or neither cytokine (p = 0.0005)
and contained more TRECs than cells coproducing CXCL8 and
IL-2, as shown by individual tracking lines (Fig. 1D). Likewise,
CXCL8+CD4+ T cells from children (n = 10, aged ,12 y) were
highly enriched in TRECs (Fig. 1E). Thus, CXCL8 production
was associated with the most immature of naive peripheral T cells
in adults, as well as in children. In contrast, IFN-g–producing
CD4+ cells from each of three adults examined were almost
completely depleted of TRECs (Fig. 1F). Interestingly, another
scenario in which CXCL8 production was associated was primary
T-ALL samples including those with a more mature T cell (T-III/
T-IV) classification (22) (gray diamonds, n = 6 of 12 T-ALL
samples, Fig. 1G)
CXCL8 imprinting in thymocytes
Given that CXCL8-producing CD4+ T cells are enriched among
RTEs, it was appropriate to ask whether CXCL8 expression was
induced during T cell development. Indeed, following PI-induced
activation in vitro, CXCL8 was expressed by ∼10% of total thymo-
cytes harvested from humanized mice at 37 wk post–hematopoietic
stem cell inoculation, a time point at which CXCL8 expression in
the periphery of mice was greatly diminished (Fig. 2A).
To determine at which stage(s) in human T cell development
CXCL8 expression became evident, thymocyte subsets were sorted
from pediatric human thymus and activated with PI in vitro. Cells
expressing neither CD4+ nor CD8+ (double-negative [DN] cells)
contained the most immature T cell precursors and were most
enriched in CXCL8 producers (mean 29.7%, n = 15) (Fig. 2B).
Thereafter, CXCL8 producers declined (Fig. 2B).
Because the thymocyte DN subset is highly heterogeneous, it
was re-examined, using coexpression of CD34, CD5, CD7, and
CD1a to identify T-committed cells. An average of ∼50% of such
cells were CXCL8 producers (n = 6 thymuses) (Fig. 2C). Given
that CXCL8 is produced by myeloid cells, it was not surprising
that CXCL8 production was also observed in CD1a2 DN thymo-
cytes that retain myeloid lineage potential (Supplemental Fig. 1).
Next, CXCL8 production was examined in CD4+ single-positive
(SP) thymocytes versus paired naive peripheral CD4+ T cells
containing RTEs. Interestingly, the latter harbored the greater
percentage of CXCL8 producers (p , 0.0007) (Fig. 2D), strongly
suggesting that SP thymocytes that exit the thymus are enriched in
those expressing CXCL8.
CXCL8-producing CD4+ T cells are distinct
To better understand CXCL8-producing T cells, CD4+ cells pas-
sively purified from CB by negative selection were activated with
PI, and single cells were captured using the C1 Single-Cell Auto
Prep System (Fluidigm). A total of 96 single cells (55 from one
CB and 41 from another) were selected for full transcriptomic
analysis. Total gene counts were normalized to ERCC spike-in
control counts to assess cellular RNA content and sequencing
depth. Unbiased investigation of the data by principal component
(PC) analysis identified two distinct clusters of cells (gray and
black, Fig. 3A). Of note, CXCL8 expression was one of the
strongest contributors to PC1 (x-axis in Fig. 3A), thereby driving
the discrimination of the two cell types. Contributing to this dis-
crimination were RNAs encoding two chemokines, CCL3 and
CCL4 (macrophage inflammatory protein-1a and -1b), which are
expressed by CD4+ Th1 cell progenitors in mice (Fig. 3B, see
Discussion). Spearman rank correlation (Table I) showed that
CXCL8 expression was most strongly associated with the T-bet–
inducing transcription factor EGR1 (Spearman rank correlation =
0.55), PDGFA (Spearman rank correlation = 0.54), and GMCSF
(CSF2; Spearman rank correlation = 0.49). Approximately one
Table I. Spearman rank correlation: top 50 gene associations with
CXCL8 expression
Rank Gene A Gene B Correlation
1 CXCL8 EGR1 0.5549
2 CXCL8 PDGFA 0.53694
3 CXCL8 CCL3 0.50176
4 CXCL8 CSF2 0.49463
5 CXCL8 AFTPH 0.48789
6 CXCL8 EGR3 0.48369
7 CXCL8 GAPDH 0.47071
8 CXCL8 CCL4 0.46395
9 CXCL8 SDF2 0.43786
10 CXCL8 BTLA 20.4369
11 CXCL8 CHKA 0.42098
12 CXCL8 ATP5O 0.42012
13 CXCL8 HELZ 0.41729
14 CXCL8 ZNF638 0.41004
15 CXCL8 AKAP13 0.39971
16 CXCL8 PLP2 0.39489
17 CXCL8 PLAC8 0.39369
18 CXCL8 PIKFYVE 0.39082
19 CXCL8 AP3D1 0.38813
20 CXCL8 RPS12 0.38720
21 CXCL8 DAZAP2 0.38410
22 CXCL8 PLAU 0.38267
23 CXCL8 ZC3H13 0.37866
24 CXCL8 SSR4 0.37593
25 CXCL8 ARID5B 20.3758
26 CXCL8 DUSP10 0.37505
27 CXCL8 PSMA1 0.37081
28 CXCL8 ZSWIM6 0.37014
29 CXCL8 IFITM3 0.36902
30 CXCL8 AGO2 20.36722
31 CXCL8 FAM46A 0.36690
32 CXCL8 CALM1 20.36385
33 CXCL8 TMF1 0.36253
34 CXCL8 CAP1 0.36166
35 CXCL8 MTRNR2L8 0.36091
36 CXCL8 TXNL1 0.35475
37 CXCL8 NFKBIA 0.35448
38 CXCL8 HMGN3 0.35418
39 CXCL8 CARD8 0.34913
40 CXCL8 AKIRIN2 0.34817
41 CXCL8 CRTAM 0.34734
42 CXCL8 SREK1IP1 0.34725
43 CXCL8 CD40LG 20.34713
44 CXCL8 BMPR2 0.34449
45 CXCL8 MTRNR2L2 0.33626
46 CXCL8 ACAP2 0.33592
47 CXCL8 ATP5A1 0.33311
48 CXCL8 IFITM2 0.33230
49 CXCL8 RAN 20.3313
50 CXCL8 SLC25A3 0.3279
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fifth of GM-CSF–producing T cells in infants coproduced CXCL8,
whereas ∼3% of CXCL8-producers coproduced GM-CSF (Supple-
mental Fig. 2), consistent with infants harboring more CXCL8-
producing cells than GM-CSF–producing cells. Indeed, the situation
was reversed in adults (Supplemental Fig. 2), consistent with GM-
CSF producers now outnumbering CXCL8-producing cells.
CXCL8+CD4+ T cell conversion to IFN-g producers
To better understand the fate of CXCL8-producing T cells, we
tracked the effector functions of bulk-activated, sorted, naive CB
CD4+ T cells ex vivo. Although such cells produced only CXCL8
upon initial stimulation with PI ex vivo, prolonged stimulation for
5 d with anti-CD3 plus anti-CD28 led to the appearance of IFN-g,
particularly among cells that had divided, as reflected by Cell-
Trace Violet dilution (Supplemental Fig. 3A). When cells were
stimulated with IL-7 alone, a critical factor for naive T cell survival,
there was less proliferation, but an even greater percentage of di-
vided cells expressed IFN-g (Supplemental Fig. 3A). By gating on
discrete generations from several CB CD4+ T cell samples (n = 4/5),
it was evident by the third cell division that the percentage of IFN-
g2expressing cells was significantly different from the percent-
age of IFN-g2producing cells among undivided CD4+ T cells
(Supplemental Fig. 3A). Furthermore, following several rounds
of proliferation, T-bet was induced and was largely attributable to
those CD4+ cells expressing IFN-g (Supplemental Fig. 3B). Simi-
larly, the decline over time of cells expressing CXCL8 in humanized
mice (Fig. 1C) was reciprocated by an increased percentage of cells
producing IFN-g (Supplemental Fig. 4).
To determine whether this phenotypic transition might be due to
a direct conversion of CXCL8-producing cells into those producing
IFN-g, a dual-ELISPOT (IFN-g/CXCL8 FluoroSpot) system was
adopted, in which different cytokines produced by individual cells
FIGURE 4. CXCL8+ CD4+ T cells
are precursors for conventional Th1 ef-
fectors. CXCL8/IFN-g production on a
per-cell basis is shown by the Fluo-
roSpot assay in which green spots rep-
resent IFN-g production, and red spots
represent CXCL8 production. A merged
image to show dual-positive spots is
shown for each case; the number of
dual-positive spots in the well is anno-
tated on the top right of each image.
Corresponding pie charts depict the
percentage of IFN-g+ (green), CXCL8+
(red), and CXCL8+IFN-g+ (yellow) spots
from all of the samples. Naive CD4+
T cells isolated from six cord samples
were stimulated ex vivo (20 h PI or anti-
CD3+CD28 beads) (A) and for 72 h
(anti-CD3+28 beads, followed by PI
restimulation for the last 20 h) (B). All
experiments were performed in dupli-
cate at a range of cell titrations. All wells
depicted had between 7.5 and 22.53 103
cells per well. Examples of dual-positive
spots are shown at a higher magnifica-
tion (right panel). (C) Overnight PI stim-
ulation (10,000 sorted CD4+ T cells
per well) for cord and for adult CD4+
T cells. Corresponding pie charts de-
pict the percentage of IFN-g+ (green),
CXCL8+ (red), and CXCL8+IFN-g+
(dual-yellow) spots.
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over the time-course of the assay are captured in situ on a poly-
vinylidene difluoride membrane. PI activation of naive CD4+
T cells sorted from several CB samples (n = 8) primarily induced
CXCL8 (99.74%) over an initial 20-h period (Fig. 4A). Use of
anti-CD3+CD28 beads to activate sorted naive CD4+ T cells in-
duced slightly more (,6%) IFN-g–producing cells (lower panel,
Fig. 4A), but neither PI nor anti-CD3+CD28 induced any dual-
positive cells (i.e., there was a lack of yellow spots) among
CB cells. However, when naive CD4+ T cells were allowed to
proliferate by sustained activation for 52 h with anti-CD3+CD28,
prior to PI stimulation, the percentage of IFN-g+ spots was in-
creased, and more than one third were CXCL8+IFN-g+ dual-positive
cells (yellow spots, Fig. 4B). The fact that no dual-positive cells
were detected at 20 h argues against the assay being confounded
by the supposition of two cells with different effector functions.
Rather, it strongly suggests that some single cells acquired a
second effector function over time.
As would be expected, PI activation of adult (age = 24 y) CD4+
T cells primarily provoked IFN-g production (green spots; Fig.
4C, right panel) in contrast to CXCL8 production by CB-derived
CD4+ T cells (red spots; Fig. 4C, left panel), However, adult CD4+
T cells included some CXCL8 producers (red spots; Fig. 4C, right
panel), of which almost 50% were also IFN-g+ (yellow spots; Fig.
4C, right panel). Taken together, the data suggest that the ca-
pacity for CD4+ T cells to coproduce IFN-g and CXCL8 exists in
adults and in neonates, raising the question of whether this re-
flects a developmental transition from CXCL8 production to IFN-g
production.
To test this, it would be appropriate to clone single CXCL8+ cells
and track them. However, no capture system for CXCL8-secreting
cells exists. Therefore, activated naive CD4+ T cells were sorted as
single cells directly into 96-well FluoroSpot plates, in which
system a single red spot in a FluoroSpot well acts as a read-out
for a CXCL8 producer. However, rather than discarding the in-
dividual cells prior to plate development, they were transferred to
the corresponding well of a 96-well U-bottom plate and then
cloned via several rounds of stimulation with PHA and irradiated
feeder cells (Fig. 5). This allowed the fates of single CXCL8-
producing cells to be tracked.
Clones derived from 10 independent CXCL8-producing cells,
isolated from adults and from CB, were expanded in this way, and
investigated for cytokine expression following PI stimulation once
sufficient cell numbers had been reached (Figs. 5–7). In parallel,
the capacity to produce IFN-g was scrutinized for 22 clones de-
rived from wells in which neither CXCL8 nor IFN-g was initially
produced (i.e., analogous to a Th0 phenotype). All 10 clones de-
rived from CXCL8-producing cells went on to produce IFN-g. In
so much as it could be assessed, IFN-g–producing cells were
obtained with comparable efficiencies from CXCL8+ clones and
Th0-derived clones, and the cloned lines derived in each case
showed comparable levels of IFN-g production (Fig. 5).
Certain clones (those that were being expanded further to derive
sufficient cell numbers for TCR sequencing) were followed for a
longer period, through to days 35 and 53. At both time points, a
substantial fraction (often ∼90% of cells) of each clone produced
IFN-g (Fig. 6) and many also produced IL-2 (Fig. 7). Of note, the
cultures coproduced CXCL8, but this declined over time (Fig. 6),
consistent with the time-dependent appearance of IFN-g single-
producers in the dual-ELISPOT assay (above) and with the re-
duction in CXCL8 production with age (Fig. 1). Thus, the mean
ratio of IFN-g+ (single-producers) to CXCL8+IFN-g+ (double
producers) prior to day 38 (addition of fourth round of feeders)
was 2:1 (n = 5 clones), whereas this increased at later time points
to a mean of 6:1 (n = 4). In contrast, there was no reproducible
evidence for single CXCL8-producing cells giving rise to IL-17A
or IL-4 producers (Fig. 7), although under the standardized cloning
conditions used, we and other investigators have observed the
generation of T cell clones with a Th2 phenotype.
Having established that cells derived from a single CXCL8
producer could express IFN-g alone or be dual IFN-g/CXCL8
producers, it was important to verify the cells’ clonality. Adult
clones E11 and C8 were sampled for DNA at day 41, and CB clones
C9 and B4 were sampled at day 53, whereupon sequencing iden-
tified, in every case, a single a- and b-chain (Va27-Vb18 [C9],
Va12Vb7 [B4], Va8Vb7 [E11], and Va21Vb19 [C8]), with single
CDR3 sequences for each chain (Fig. 6). Moreover, the TCRa-
CDR3 sequence for C9 was identical to that identified when seven
single cells of clone C9 were sequenced on day 38. These data
confirm that each culture represents a clonal population derived
from single CXCL8-producing CD4+ T cells that progresses to
include IFN-g–producing cells and CXCL8/IFN-g dual producers.
Thus, Th1 effector cells can derive from single CXCL8-producing
CD4+ T cells that are common among RTEs of babies, children,
and adults.
Discussion
The data presented in this study show that the primary effector
potential enriched in CD4+ RTEs in adults, as well as in children,
is CXCL8 production and that such T cells may convert to a
classic adaptive Th1-type effector cell following sustained pro-
liferation, as would occur following Ag priming in the lymph
nodes. Thus, these data highlight that CXCL8 production does not
represent end-stage differentiation; instead, CXCL8+ cells can
FIGURE 5. Schematic diagram demonstrating how single-cell sorting in
FluoroSpot plates was performed. Inset: production of IFN-g is shown for
10 clones derived from CXCL8+ cells and 22 clones derived from Th0
cells, with a representative FluoroSpot well shown above for a CXCL8+
well and a Th0 well. Clones were harvested after sufficient cell numbers
had been reached and were stimulated with PI for 4 h prior to staining and
acquisition.
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differentiate into a more conventional T cell phenotype. This model
of human T cell differentiation is in stark contrast to the current
model by which “functionless” Th0 cells are the progenitors of Th1
cells. Nonetheless, several data sets are consistent with our findings.
Most directly, bulk human CXCL8-producing cells were shown
to give rise to IFN-g–producing cells following TCR activation
and/or cytokine-induced proliferation in vitro; however, because
the analysis was not undertaken at a single-cell level, bona fide
phenotypic conversion could not be distinguished from the out-
growth of existing IFN-g–producing cells (23, 24). In a parallel
study, it was shown that mouse Th1 cells could derive from T cells
producing IL-17 (7). Interestingly, mouse IL-17–producing cells
may, in several ways, be parallel to human CXCL8-producing
T cells, including their capacity to activate neutrophils, a major
function of human CXCL8 that is largely assumed by IL-17 in
mice (which lack the CXCL8 gene) (8, 9). Third, CCL3 and CCL4
gene expression cosegregate with CXCL8 expression, just as they
are markers of CD4+ Th1 progenitors in mice (25).
The capacity of a T cell to deliver effector function prior to clonal
proliferation and Th1 differentiation would seem a highly efficient
device to provide a rapid innate-like barrier to bacterial dissemi-
nation that would be particularly useful in neonates in whom RTEs
are preferentially enriched. This inner core of innate activity is shed
in favor of an adaptive Th1 end state for cells provoked into
sustained proliferation by Ag stimulation and coreceptor signaling,
which simultaneously provide the necessary quality control to limit
autoimmunity. The strong correlation of CXCL8 gene expression
with EGR1 gene expression highlights the propensity for Th1
skewing of CXCL8-producing cells because EGR1 is a regulator
of Tbx21 gene (T-bet) induction during Th1 polarization (26).
Indeed, human T-BET protein induction could be observed in CB-
derived CD4+ cells after several rounds of proliferation, coincident
with the competence to express IFN-g. Whether the conversion to
IFN-g production is T-BET dependent in these cells has not been
formally assessed. Possibly the switch to aerobic glycolysis in-
duced by sustained proliferation is a contributory driver of con-
version (27). In so much as it could be assessed in this study,
clones derived from CXCL8+ CD4+ T cells seemed comparable to
their Th0 counterparts in generating Th1 effectors. Likewise,
although we provide clear evidence that single CXCL8+ CD4+
T cells can give rise to IFN-g–producing CD4+ T cells, we do not
exclude their potential to also differentiate into more diverse effector
T cell types.
Our demonstration, by TREC analysis, that CXCL8 production
is a feature of RTEs is also consistent with the observation of
diminished CXCL8 production in thymectomized children (24).
However, the data might be viewed as inconsistent with the pro-
posed discontiguity of fetal/neonatal and adult immune systems,
FIGURE 6. Clones derived from a single CXCL8-producing cell produce IFN-g. Activated (2 h PI) naive CD4+ T cells were single-cell sorted directly
into 96-well FluoroSpot plates. Single cells were recovered from the FluoroSpot plate and added to PHA (4 mg/ml) and irradiated feeder cells for cloning.
The FluoroSpot plate was developed to reveal a signal left by a single CXCL8-producing cell. Cells cloned were subsequently stimulated (PI; 4 h) at two
time points, and dot plots depicting IFN-g (x-axis) and CXCL8 (y-axis) production at each time point are shown. To show clonality, sequencing of TCRa-
and b-chains was performed using DNA extracted from sorted live 7-aminoactinomycin D2CD3+CD4+ T cells. The amino acid sequence for the CDR3
region and gene usage are shown for each clone.
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with regulatory T cell (Treg) generation considered a default
pathway for neonatal T cells (5, 28). Indeed, very few genes
scoring significantly in our single-cell analysis of CB T cells were
related to Treg function. However, the data sets might be recon-
ciled if Treg function, like IFN-g function, arises primarily after
cell proliferation, thereby to limit the potency of emerging effector
T cells. Indeed, in almost all systems in which they have been ex-
amined, Treg frequencies correlate with those of CD4+ T effector/
memory cells (29, 30).
Although CXCL8 expression was acquired in the thymus by
T-lineage–committed DN cells, prior to TCR signaling, a larger
percentage of CD4+ RTEs expressed CXCL8 compared with their
paired SP CD4+ thymocyte counterparts. CXCL8 production
might be enhanced in RTEs by peripheral factors that are de-
pendent on the milieu present during primary Ag recognition (31,
32). Alternatively, because only a small subset of SP CD4+ thy-
mocytes are capable of proliferation, thymic egress, and cytokine
production (33), CXCL8 expression may correlate with factor(s)
that mark the competence of cells to exit the thymus (24); indeed,
CXCL8 might be a surrogate marker for such competence. In
agreement with this, we have observed a 2–3-fold enrichment in
CXCL8-producing cells within thymic CD4+ T cells that express
S1PR1 compared with S1PR12 cells (A. Das and D.L. Gibbons,
unpublished observations).
Finally, it is noteworthy that T-ALL of different stages also
produced CXCL8, given that CXCL8 has been established as an
indicator of poor prognosis (34). These findings might indicate that
expansion of “immature” CXCL8-producing T cells, coupled with
their failure to differentiate toward Th1 cells, is a pathognomonic
feature of the disease, meriting further investigation.
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Supplementary Figure 1. CXCL8 is produced by both CD1a negative and CD1a positive 
DN thymocytes.  
CD1a is a marker of T cell lineage commitment. Shown here is a representative FACS plot, 
demonstrating CXCL8 production in DN thymocytes following ex vivo stimulation with PI 
against CD1a expression. CXCL8 production (shown as a percentage and mean fluorescence 
intensity MFI) within the CD34+CD7+CD5+CD1a negative population is consistent with the 
myeloid lineage potential of these cells. 
  
Supplementary Figure 2 
 
  
Supplementary Figure 3 
 
Supplementary Figure 3. Tracking the fate of neonatal CXCL8+ CD4+ T cells 
A. Stimulation ex vivo with PI induced CXCL8 but not IFN- (representative FACS plot shown). 
To track the fate of these cells, cord CD4+ T cells were labeled with cell trace violet (x axis) and left 
for 5 days with anti-CD3+CD28 beads or with IL7 alone to induce proliferation followed by 
restimulation with PI. Graphs to the right depict the mean % of IFN- production in each successive 
generation following PI re-stimulation. 
B. Density plots show total CD4 T cells stained with isotype (left) or T-bet (right) 5 days post 
labeling with cell trace violet and stimulation with anti-CD3+CD28 beads. Following re-stimulation 
with PI, T-bet expression was analysed in IFN- negative (top histogram) or IFN- positive (bottom) 
CD4 T cells 
Supplementary Figure 4 
 
 
Supplementary Figure 4. IFN- expressing T cells increase in humanised mice over 
time. 
Irradiated NSG mice were reconstituted with human CD34+ cells (cord blood derived).  
A. FACS plots show an example of IFN- production within CD3+ T cells (PI + BFA for 
4 hrs) in one reconstituted NSG mouse over time (the same mouse as shown in Fig 
1c);  
B. The graph shows decline in T cell production of CXCL8 (black lines) over time in 
individual mice with a reciprocal increase in T cell production of IFN- (grey lines) 
